Pain-pill giant Purdue Pharma LP will stop promoting its opioiddrugs to doctors, a retreat after years of criticism that thecompany’s aggressive sales efforts helped lay thefoundation of the U.S. addiction crisis.
The company told employees this week that it would cut its salesforce by more than half, to 200 workers. It plans to send a letterMonday to doctors saying that its salespeople will no longer cometo their clinics to talk about the company’s pain products.
“We have restructured and significantly reduced our commercialoperation and will no longer be promoting opioids to prescribers,”the company said in a statement. Instead, any questions doctorshave will be directed to the Stamford, Connecticut-basedcompany’s medical affairs department.
Continue Reading for Free
Register and gain access to:
- Breaking benefits news and analysis, on-site and via our newsletters and custom alerts
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical converage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
Already have an account? Sign In Now
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
